APTAMER GROUP

aptamer-group-logo

The Aptamer group of companies focuses on the development of aptamer technologies. We develop nucleic acid aptamers for use in research & development, biomarker discovery, diagnostics or therapeutic developments. Aptamers are short DNA or RNA sequences that offer high-affinity and specificity to virtually all types of targets. They can therefore be thought of as synthetic nucleic acid equivalents of antibodies. Aptamers are versatile, cost effective and offer a complementary or alternative solut... ion to antibodies. We have over 20 years combined expertise in the development of nucleic acid aptamers to peptides, proteins, cells, tissue samples, micro-organisms and small molecules. The Aptamer Group of companies has cutting edge platforms for the selection of aptamers. These include semi-automated selection platforms which ensure accurate replication of selection conditions to ensure the best quality aptamers result. We can use a wide range of targets: peptide, proteins, whole cells, viruses, small molecules etc. The typical aptamer selection process can be completed in a matter of weeks. Monoclonal antibodies usually take several months to generate. Our custom service can be focussed on a particular application so that the resultant aptamers are pre-optimized for use with a given detection platform, sample type and assay buffer. Aptamers themselves are increasingly being perceived as the state of the art reagent of choice for a wide range of applications including: Imaging experiments: fluorescence, bright field and phase contrast, IHC, ICC Quantification: ELISA (or ELONA), homogeneous assays etc. Rapid diagnostics: Lateral flow devices, biosensors, electrochemical detection, nano-wires Binding studies: label free detection, SPR, Biolayer Interferometry Purification: affinity chromatography We also offer an aptamer based assay development service. Our solution can be used to identify aptamers for virtually any application and against almost any target in almost any condition. Our applications are more diverse than those for which antibodies have been used. These include therapeutics, in biomarker discover, in drug target discovery, as diagnostics, in biosensors as components of biochemical tests such as Lateral flow devices, enzyme linked oligonucleotide assays (ELONA: the aptamer based equivalent of ELISA), in affinity chromatography and as research reagents. For more information visit: www.aptamergroup.com

#SimilarOrganizations #People #Financial #Event #Website #More

APTAMER GROUP

Social Links:

Industry:
Biotechnology Health Care Health Diagnostics

Founded:
2008-04-12

Address:
York, York, United Kingdom

Country:
United Kingdom

Website Url:
http://www.aptamergroup.com

Total Employee:
1+

Status:
Active

Contact:
+44 (0) 1904 567 790

Email Addresses:
[email protected]

Total Funding:
8.42 M USD

Technology used in webpage:
Person Schema Facebook Sharer Gravatar Profiles Pinterest German Server Location Reddit


Similar Organizations

altheadx-logo

AltheaDx

AltheaDx offers molecular diagnostics and PCR-based services such as molecular biomarker discovery, assay development and assay validation.

idenix-pharmaceuticals-logo

Idenix Pharmaceuticals

Idenix Pharmaceuticals is focused on the discovery and development of drugs for the treatment of human viral diseases.

intarcia-therapeutics-logo

Intarcia Therapeutics

Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.

molecular-health-logo

Molecular Health

Molecular Health offers software solutions for evidence-based healthcare decision support and smarter drug development.

oxford-biotherapeutics-logo

Oxford BioTherapeutics

Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs.

radius-health-logo

Radius Health

Radius Health develops drug therapies for osteoporosis and womenโ€™s health.

Current Employees Featured

jordan-clark_image

Jordan Clark
Jordan Clark Chief Commercial Officer @ Aptamer Group
Chief Commercial Officer
2021-06-01

david-bunka_image

David Bunka
David Bunka Director & CTO @ Aptamer Group
Director & CTO
2014-05-01

arron-tolley_image

Arron Tolley
Arron Tolley Chief Executive Officer @ Aptamer Group
Chief Executive Officer
2014-05-01

Founder


arron-tolley_image

Arron Tolley

david-bunka_image

David Bunka

Stock Details


Company's stock symbol is LSE:APTA

Investors List

nicholas-slater-b38d_image

Nicholas Slater

Nicholas Slater investment in Post-IPO Equity - Aptamer Group

adam-hargreaves-bb8b_image

Adam Hargreaves

Adam Hargreaves investment in Post-IPO Equity - Aptamer Group

eurostars_image

Eurostars

Eurostars investment in Grant - Aptamer Group

meneldor_image

Meneldor

Meneldor investment in Series A - Aptamer Group

b-i-f_image

BIF Partners

BIF Partners investment in Series A - Aptamer Group

Key Employee Changes

Date New article
2021-06-10 Aptamer Group appoints Jordan Clark as Chief Commercial Officer

Official Site Inspections

http://www.aptamergroup.com Semrush global rank: 11.54 M Semrush visits lastest month: 156

  • Host name: 6.17.214.35.bc.googleusercontent.com
  • IP address: 35.214.17.6
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "Aptamer Group"

Aptamer Group (AIM:APTA) Company Profile & Description

May 27, 2025 Company profile for Aptamer Group PLC (AIM:APTA) with a description, list of executives, contact details and other key facts.See details»

APTAMER GROUP PLC APTA Our story - London Stock Exchange

Aptamer Group is a leading provider of aptamer selection services and developer of aptamer-based reagents for use in research, bioprocessing, diagnostic, and therapeutic applications. โ€ฆSee details»

Aptamer Group - Crunchbase Company Profile

Aptamer Group develop DNA and RNA nucleic acid aptamers for use in R&D, biomarker discovery, diagnostics or therapeutic developments.See details»

Aptamer Group Information - RocketReach

Aptamer Group is a Biotechnology, Biotechnology Research, and Bio-Marker Discovery company located in York, England with 36 employees. Find top employees, contact details and business โ€ฆSee details»

Aptamer Group - Overview, News & Similar companies

Jul 31, 2023 View Aptamer Group (www.aptamergroup.com) location in North Yorkshire, United Kingdom , revenue, industry and description. Find related and similar companies as well as โ€ฆSee details»

Aptamer Group - biosciencetechnology.com

The Aptamer group brings together various aptamer technology driven companies to provide a range of services to the life sciences industry. We develop nucleic acid aptamers for use in โ€ฆSee details»

Aptamer Group - Craft

Aptamer Group has 5 employees across 2 locations. See insights on Aptamer Group including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

Aptamer Group 2025 Company Profile: Stock โ€ฆ

Information on stock, financials, earnings, subsidiaries, investors, and executives for Aptamer Group. Use the PitchBook Platform to explore the full profile.See details»

Investor Relations - Aptamer Group

Aptamer Group is a leading provider of aptamer selection services and developer of aptamer-based reagents for use in research, bioprocessing, diagnostic, andSee details»

The Aptamer Group - VentureRadar

Aptamer Group Limited United Kingdom Privately Held Aptamer Group is a world-leading provider of custom aptamer selection and development services. We utilise our many years of โ€ฆSee details»

Aptamer Group - 2025 Company Profile - Tracxn

Mar 12, 2025 Aptamer Group - Manufacturer of DNA and RNA nucleic acid aptamers for use in research & development. Public Company. Raised a total funding of $2.2M over 4 rounds from โ€ฆSee details»

Aptamer Group - InsideScientific

Mar 21, 2024 Aptamer Group is the developer of custom affinity tools for the life science industry through its proprietary Optimer ® platform.See details»

Aptamer Group - Neuroscience 2023

Nov 15, 2023 Aptamer Group develops custom affinity binders for use across the life sciences using its proprietary Optimer® platform. Optimer affinity ligands are oligonucleotide-based โ€ฆSee details»

The Team - Aptamer Group

Windmill House, Innovation Way, York, YO10 5BR, UK Tel: +44 (0) 1904217404 Email: [email protected]See details»

Aptamer Group Overview | SignalHire Company Profile

The Aptamer group of companies focuses on the development of aptamer technologies. We develop nucleic acid aptamers for use in research & development, biomarker discovery, โ€ฆSee details»

About - Aptamer Group

At Aptamer Group, we have successfully delivered projects for global pharma companies, diagnostic development companies, and research institutes covering a range of targets and โ€ฆSee details»

Reports And Presentations - Aptamer Group

Full results for the year ended 30 June 2024 presentation slides Full results for the year ended 30 June 2024 presentation videoSee details»

Is Aptamer Groupโ€™s Optimer the Future of Liver Disease Treatment?

Apr 26, 2024 The Rise of Aptamer TechnologyLiver diseases, particularly fibrotic disorders, represent a significant health burden worldwide. The quest for more effective therapies has led โ€ฆSee details»

Aptamer Group - Profiles & Contacts - Crunchbase

Aptamer Group develop DNA and RNA nucleic acid aptamers for use in R&D, biomarker discovery, diagnostics or therapeutic developments.See details»

Aptorum Group Limited and DiamiR Biosciences Enter into

2 days ago Aptorum Group Limited and DiamiR Biosciences Enter into Definitive Merger Agreement July 16, 2025 08:38 ET | Source: Aptorum Group Ltd FollowSee details»

linkstock.net © 2022. All rights reserved